Lacklustre debut for RaQualia in Japan
This article was originally published in Scrip
Executive Summary
Shares in the Japanese drug development venture RaQualia Pharma began trading below their offer price on 20 July, reflecting apparent investor caution over a new business plan released by the company the same day.